ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 1942

$491K Total Retail Price of All Prescriptions

Rank: 105 out of 1942

462 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 437 387 1 1
LISINOPRIL 416 377 2 2
OMEPRAZOLE 304 271 3 4
METOPROLOL TARTRATE 291 285 4 9
FUROSEMIDE 275 258 5 5
ATENOLOL 275 246 5 7
LEVOTHYROXINE SODIUM 256 220 7 3
METFORMIN HCL 254 209 8 10
WARFARIN SODIUM 223 206 9 11
HYDROCODONE-ACETAMINOPHEN 216 201 S3 10 12
ALENDRONATE SODIUM 209 195 11 21
FENTANYL 169 134 S2 12 47
POLYETHYLENE GLYCOL 3350 160 122 13 28
LOSARTAN POTASSIUM 153 149 14 18
PREDNISONE 152 139 15 27
POTASSIUM CHLORIDE 147 123 16 17
CITALOPRAM HBR 143 128 17 15
HYDROCHLOROTHIAZIDE 137 135 18 8
GABAPENTIN 124 79 19 16
AMLODIPINE BESYLATE 120 118 20 6
SERTRALINE HCL 120 117 20 20
JANTOVEN 114 114 22 33
MORPHINE SULFATE ER 112 20 S2 23 88
METHYLPREDNISOLONE 112 90 23 191
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 93 25 22
HUMALOG 109 104 26 159
FLUTICASONE PROPIONATE 107 73 27 37
DIGOXIN 105 105 28 40
METOPROLOL SUCCINATE 105 101 28 13
ATORVASTATIN CALCIUM 103 86 30 14
FLUOXETINE HCL 102 78 31 45
RANITIDINE HCL 100 51 32 31
CARVEDILOL 98 95 33 39
LANTUS 98 98 33 49
LANTUS SOLOSTAR 92 73 35 54
LOSARTAN-HYDROCHLOROTHIAZIDE 89 84 36 67
PAROXETINE HCL 87 40 37 50
TRAMADOL HCL 84 53 38 19
ZOLPIDEM TARTRATE 80 74 39 25
EVISTA 71 71 40 126
ALLOPURINOL 68 60 41 26
CARBIDOPA-LEVODOPA 67 67 42 64
DONEPEZIL HCL 64 64 43 30
CLOPIDOGREL 63 61 44 55
AZITHROMYCIN 61 42 45 43
AMITRIPTYLINE HCL 60 44 R 46 65
LOVASTATIN 60 60 46 32
DILTIAZEM 24HR CD 59 58 48 74
ADVAIR DISKUS 59 44 48 35
AMOXICILLIN 57 48 50 151
DIOVAN 56 53 51 44
PREMARIN 56 37 R 51 209
MIRTAZAPINE 54 54 53 38
VITAMIN D2 53 53 54 156
PRAVASTATIN SODIUM 52 52 55 23
OXYCODONE-ACETAMINOPHEN 51 0 S2 56 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 42 57 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.